Optimal two-stage design for a series of pilot trials of new agents

Biometrics

Volumn 54, Issue 3, 1998, Pages 1183-1189

  Yao, Tzy Jyun ^a   Venkatraman, E S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bootstrap; Empirical Bayes; Screening clinical trials; Two stage design

Indexed keywords

BOOTSTRAP; CLINICAL TRIAL; EMPIRICAL BAYES; ERROR RATE; HISTORICAL EXPERIENCE; KETTERING; NEW THERAPEUTIC AGENT; SAMPLE SIZES; SCREENING CLINICAL TRIAL; TWO STAGE DESIGNS;

SCREENING;

ACCURACY; ARTICLE; BIOMETRY; DATA ANALYSIS; DRUG RESEARCH; RELIABILITY; SAMPLE; VACCINATION;

EID: 0031679258     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533868     Document Type: Article

References (11)

1. Atkinson, E. N. and Brown, B. W. (1985). Confidence limits for probability of response in multistage phase II clinical trials. Biometrics 41, 741-744.
2. DeMets, D. L. and Ware, J. H. (1980). Group sequential methods for clinical trials with a one-sided hypothesis. Biometrika 66, 651-660.
3. DeMets, D. L. and Ware, J. H. (1982). Asymmetric group sequential boundaries for monitoring clinical trials. Biometrika 69, 661-663.
4. Ellenberg, S. S. and Eisenberger, M. A. (1985). An efficient design for phase III studies of combination chemotherapies. Cancer Treatment Report 69, 1147-1154.
5. Mariani, M. and Marubini, E. (1996). Design and analysis of phase II cancer trials: A review of statistical methods and guidelines for medical researchers. International Statistical Review 64, 61-88.
6. McPherson, K. (1982). On choosing the number of interim analyses in clinical trials. Statistics in Medicine 1, 25-36.
7. Press, W. H., Teukolsky, S. A., Vetterling, W. T., and Flannery, B. P. (1992). Numerical Recipes in FORTRAN. The Art of Scientific Computing, 2nd edition. Cambridge: Cambridge University Press.
8. Simon, R. (1989). Optimal two-stage designs for Phase II clinical trials. Controlled Clinical Trials 10, 1-10.
9. Thall, P. F. and Simon, R. (1990). Incorporating historical control data in planning phase II clinical trials. Statistics in Medicine 9, 215-228.
10. Thall, P. F., Simon, R., Ellenberg, S. S., and Shrager, R. (1988). Optimal two-stage designs for clinical trials with binary response. Statistics in Medicine 7, 571-579.
11. Yao, T. J., Begg, C. B., and Livingston, P. O. (1996). Optimal sample size for a series of pilot trials of new agents. Biometrics 52, 992-1001.